A patient was on treatment with trifluperazine for some time. He presents with complaint of hypehermia, lethargy and sweating. Needed investigations are
## **Core Concept**
The patient's symptoms of hyperthermia, lethargy, and sweating, occurring while on treatment with trifluperazine, suggest Neuroleptic Malignant Syndrome (NMS). NMS is a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic medication. Trifluperazine is a typical antipsychotic that can cause this condition.
## **Why the Correct Answer is Right**
The correct approach to diagnosing and managing suspected NMS involves several key investigations. These include:
- **Complete Blood Count (CBC)**: To assess for signs of infection or inflammation.
- **Blood Chemistry Tests**: Including liver function tests, renal function tests, and electrolytes, to evaluate the extent of metabolic derangement.
- **Creatine Kinase (CK) Levels**: Elevated CK levels are a hallmark of muscle damage in NMS.
- **Thyroid Function Tests**: Although not directly diagnostic, they help rule out thyroid storm, which can present similarly.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might not include all necessary tests like CK levels, which are crucial for diagnosing NMS.
- **Option B:** Similarly, this might lack specificity for NMS, potentially omitting critical tests such as CK or detailed metabolic panels.
- **Option D:** This option could be too narrow, failing to account for the broad range of tests needed to diagnose and manage NMS properly.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **early recognition and withdrawal of the offending antipsychotic agent** are crucial in managing NMS, alongside supportive care. High fever, muscle rigidity, altered mental status, and autonomic dysfunction are the classic tetrad of symptoms. Remember, **NMS is a medical emergency** requiring immediate intervention.
## **Correct Answer:** C.